$RKLB

Beck Peter sold $286.4M of RKLB (indirect holdings)

Beck Peter (CEO) sold 3,275,779 indirectly-held shares of Rocket Lab Corp (RKLB) at an average of $87.43 ($81.59–$101.57, $286.41M total) across 24 trades over 2026-07-06 to 2026-07-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Beck Peter
Published Jul 9, 2026, 12:13 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
8/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The newest actionable element is the disclosed magnitude and timing window of the sales (3,275,779 shares from 2026-07-06 to 2026-07-08) and the post-transaction share count (1,724,221).

02

Market read

Traders may adjust short-term sentiment or positioning around insider-selling headlines, but the 10b5-1 designation reduces fundamental interpretation.

03

What to watch

The filing reports indirect holdings and a range of sale prices; traders should avoid inferring a single directional view from the average price alone.

Relevance 8/10Novelty 6/10Timing: new Form 4 filed after-hours on 2026-07-08, covering sales from 2026-07-06 to 2026-07-08

Background

This is an SEC Form 4 insider transaction by Rocket Lab CEO Beck Peter, coded as an open-market sale with a stated pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab CEO Beck Peter sold $286.4M of RKLB shares via an open-market sale under a 10b5-1 plan, reducing holdings to 1,724,221.

Expected impact

Mild negative to neutral short-term sentiment impact; likely limited fundamental read-through given 10b5-1 pre-arrangement.

Evidence & confidence

The filing is a primary-source Form 4 showing a very large sale ($286.4M) across 24 trades, but it explicitly states a pre-arranged 10b5-1 plan, which reduces interpretive weight versus non-plan sales.

Market effects

Limited sector read-through; this is company-specific insider activity rather than a sector catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect liquidity planning rather than negative expectations, so the market reaction could be overstated.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider sale; CEO Beck Peter sold $286.4M of RKLB shares under a 10b5-1 plan.

  • Beck Peter

    CEO and officer/director who executed the open-market sale of RKLB shares via indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBMed

Is RKLB Stock A Buy Or A High-Beta Trap?

Rocket Lab (RKLB) trades at $66, down 56% from its 52-week high, with a high P/S ratio. Q2 2026 revenue was $234M, up 62% YoY, mainly from Space Systems. Neutron rocket launch and Iridium acquisition are delayed. Backlog is $2.36B. Management expects slow growth from Iridium.

$RKLBHighAI 8/10

Rocket Lab Falls 6% as SpaceX Flags Iridium Deal to the FCC, Intuitive Machines Slides 5%

Rocket Lab (RKLB) fell 6% to $63.82 after SpaceX filed an FCC complaint against Iridium, which could impact Rocket Lab's $8B acquisition. The deal's variable exchange ratio ties Iridium payouts to Rocket Lab's share price, amplifying regulatory risks. Intuitive Machines (LUNR) and AST SpaceMobile (ASTS) also slid 5% and 6% respectively, following broader sector weakness.

$RKLBHighAI 9/10

Rocket Lab's HASTE Is Flying Hypersonic Missions for the Pentagon. Here's the Defense Business Hiding Inside a Space Stock.

Rocket Lab (RKLB), a smaller competitor to SpaceX (SPCX), has developed HASTE, a suborbital launch vehicle for hypersonic testing, primarily for the Department of Defense. HASTE offers lower-cost, frequent testing, generating higher revenue per flight than standard Electron launches. Rocket Lab has secured around $500 million in HASTE contracts, contributing significantly to its projected 2026 revenue. The company also operates in satellite manufacturing and plans to expand with the acquisition

$INTCHighAI 8/10

Why Are Nasdaq, Dow Futures Trading Mixed Premarket? INTC, SLS, SPCX, RKLB, ASTS, RIOT, FRMI Stocks Are In Focus

U.S. stock futures were mixed on Tuesday, with Nasdaq and Russell 2000 futures up 0.1%, Dow futures down 0.1%, and S&P 500 futures flat. Investors await July CPI data and geopolitical tensions impact sentiment. Key earnings reports include SMCI, CRWV, CAVA, LITE, and SLS. NVDA labeled AI data centers as investable assets, INTC upsized its share sale to $20B, and RIOT secured a $9.1B deal. RKLB shares fell despite a revenue beat, ASTS extended selloff, and SPCX faced lockup expiration pressures.

$RKLBMedAI 8/10

Rocket Lab Stock: Bull vs. Bear

Rocket Lab (RKLB +2.04%) reported record revenue of $234M in Q2 2026, up 62% YoY, with a backlog of $2.36B. The company secured U.S. Space Force contracts but delayed its Neutron rocket launch. Despite growth, it trades at 51x sales and reported a $49M net loss in Q2. Neutron's success is critical for future profitability.